Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation-Reference-Cited by-同舟云学术

Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation

Published:2016-01-18 Issue:4 Volume:16 Page:1266-1275
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Mujtaba M. A.¹,Komocsar W. J.²,Nantz E.²,Samaniego M. D.³,Henson S. L.⁴,Hague J. A.⁵,Lobashevsky A. L.⁶,Higgins N. G.⁶,Czader M.⁷,Book B. K.⁴,Anderson M. D.⁸,Pescovitz M. D.,Taber T. E.⁸

Affiliation:

1. Division of Nephrology; University of Texas Medical Branch; Galveston TX

2. Bio-Medicines Business Unit; Eli Lilly and Company; Indianapolis IN

3. Department of Internal Medicine-Nephrology; University of Michigan Health System; Ann Arbor MI

4. Department of Surgery; Indiana University School of Medicine; Indianapolis IN

5. Clinical Trial Management; Eli Lilly and Company; Indianapolis IN

6. Transplant Immunology; Indiana University Health; Indianapolis IN

7. Department of Pathology and Laboratory Medicine; Indiana University School of Medicine; Indianapolis IN

8. Department of Medicine-Nephrology; Indiana University School of Medicine; Indianapolis IN

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference33 articles.

1. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients;Port;JAMA,1993

2. Presensitization: The problem and its management;Jordan;Clin J Am Soc Nephrol,2006

3. The quality of life of patients with end-stage renal disease;Evans;N Engl J Med,1985

4. The quality of life in renal transplantation-A prospective study;Russell;Transplantation,1992

5. 2015 15 1 34

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Analysis of B Lymphocyte Subtypes, before and after Initiation of Dialysis, in Patients with End-Stage Renal Disease;Life;2023-03-23

2. Investigation of the Vascular Calcification Situation among Maintenance Hemodialysis Patients and Analysis of Its Risk Factors in Single Center;Advances in Clinical Medicine;2023

3. Investigational drugs for the treatment of kidney transplant rejection;Expert Opinion on Investigational Drugs;2022-10-03

4. BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization;Transplant Immunology;2021-12

5. Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient;Journal of Clinical Medicine;2021-08-18